{"id":"https://openalex.org/W3109317954","doi":"https://doi.org/10.2174/9789811461835120030011","title":"Antimicrobial Therapeutic Drug Monitoring","display_name":"Antimicrobial Therapeutic Drug Monitoring","alternate_titles":[],"publication_year":2020,"publication_date":"2020-11-17","ids":{"openalex":"https://openalex.org/W3109317954","doi":"https://doi.org/10.2174/9789811461835120030011","mag":"3109317954"},"language":"en","primary_location":{"id":"doi:10.2174/9789811461835120030011","doi":"https://doi.org/10.2174/9789811461835120030011","is_oa":false,"landing_page_url":"https://doi.org/10.2174/9789811461835120030011","pdf_url":null,"source":{"id":"https://openalex.org/S4210228492","display_name":"Frontiers in anti-infective agents","issn_l":"2705-1072","issn":["2705-1072","2705-1080"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Anti-infective Agents","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W4234499077","display_name":"21st Century Challenges in Antimicrobial Therapy and Stewardship","relationship":"volume"}],"lineage":["https://openalex.org/W3109317954","https://openalex.org/W4234499077"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033341289","display_name":"Rim W. Rafeh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rim W. Rafeh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055980876","display_name":"Kamilia Abdelraouf","orcid":"https://orcid.org/0000-0003-2524-352X","observed_orcids":["https://orcid.org/0000-0003-2524-352X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kamilia Abdelraouf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074376458","display_name":"Nisrine Haddad","orcid":"https://orcid.org/0000-0002-2239-6240","observed_orcids":["https://orcid.org/0000-0002-2239-6240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nisrine Haddad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011164711","display_name":"Nesrine Rizk","orcid":"https://orcid.org/0000-0002-2043-7133","observed_orcids":["https://orcid.org/0000-0002-2043-7133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nesrine Rizk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081142003","display_name":"Ahmed Fawzy EL\u2010Yazbi","orcid":"https://orcid.org/0000-0003-3432-3038","observed_orcids":["https://orcid.org/0000-0003-3432-3038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed F. El-Yazbi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"263","last_page":"297"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":1.0},{"id":"https://openalex.org/keywords/antimicrobial-agents","display_name":"antimicrobial agents","score":0.8040000200271606},{"id":"https://openalex.org/keywords/antibiotics","display_name":"antibiotics","score":0.9160000085830688},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7950000166893005},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9380000233650208},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6389999985694885},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7400000095367432},{"id":"https://openalex.org/keywords/narrow-therapeutic-index","display_name":"narrow therapeutic index","score":0.8080000281333923},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.949999988079071},{"id":"https://openalex.org/keywords/patient-populations","display_name":"patient populations","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.7233617305755615},{"id":"https://openalex.org/C2909960733","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial drug","level":3,"score":0.6766117215156555},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5927200317382812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4515773355960846},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.4513307809829712},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35496199131011963},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.301469087600708},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2264276146888733},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20663335919380188}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/9789811461835120030011","doi":"https://doi.org/10.2174/9789811461835120030011","is_oa":false,"landing_page_url":"https://doi.org/10.2174/9789811461835120030011","pdf_url":null,"source":{"id":"https://openalex.org/S4210228492","display_name":"Frontiers in anti-infective agents","issn_l":"2705-1072","issn":["2705-1072","2705-1080"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Anti-infective Agents","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1561900493","https://openalex.org/W7222406078","https://openalex.org/W4387470900","https://openalex.org/W2980807027","https://openalex.org/W7203561465","https://openalex.org/W4411738543","https://openalex.org/W1982145027","https://openalex.org/W4408346819","https://openalex.org/W2601463690","https://openalex.org/W2079531147"],"abstract_inverted_index":{"Therapeutic":[0],"Drug":[1],"Monitoring":[2],"(TDM)":[3],"is":[4,34,75,91,101],"the":[5,9,23,54,95,131],"art":[6],"of":[7,11,57,67,133],"measuring":[8],"levels":[10,152],"a":[12,50,78],"therapeutic":[13,32,61],"agent":[14],"in":[15,25,70,86,92,98,119,135],"body":[16],"fluids,":[17],"most":[18],"commonly":[19],"plasma,":[20],"and":[21,36,139,150],"interpreting":[22],"results":[24],"order":[26,120],"to":[27,43,52,77,82,110,121],"adjust":[28],"dosing":[29],"such":[30,125],"that":[31,112],"benefit":[33,85],"maximized":[35],"toxic":[37],"effects":[38,56],"are":[39,115,153],"prevented.":[40],"With":[41],"respect":[42],"antibiotics,":[44],"TDM":[45,74,134],"was":[46],"traditionally":[47],"viewed":[48],"as":[49],"method":[51,79],"curtail":[53],"side":[55],"agents":[58],"with":[59,64,124,143],"narrow":[60],"indices.":[62],"However,":[63],"improved":[65],"understanding":[66],"pharmacokinetic":[68,89],"differences":[69],"various":[71],"patient":[72,137],"populations,":[73],"evolving":[76],"by":[80],"which":[81],"ensure":[83,111],"adequate":[84],"patients":[87],"whose":[88],"status":[90],"question.":[93],"Moreover,":[94],"ever-increasing":[96],"surge":[97],"antimicrobial-resistant":[99],"organisms":[100],"calling":[102],"for":[103,140],"this":[104,108],"practice":[105],"once":[106],"more,":[107],"time":[109],"drug":[113,151],"concentrations":[114],"maintained":[116],"sufficiently":[117],"large":[118],"combat":[122],"infections":[123],"organisms.":[126],"This":[127],"book":[128],"chapter":[129],"details":[130],"use":[132],"different":[136,141],"populations":[138],"antimicrobials,":[142],"emphasis":[144],"on":[145],"how":[146],"reference":[147],"PK/PD":[148],"parameters":[149],"determined.":[154]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3109317954","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-12-07T00:00:00"}
